Texas Med Group

Texas Med Group operates in Fort Worth, Texas, under the medical direction of Dr. Bradley Axline, a board-certified physician who oversees peptide therapy protocols and metabolic health programs. The clinic focuses on evidence-based interventions for weight management and cellular optimization, serving patients throughout Tarrant County and the Dallas-Fort Worth metropolitan area. Dr. Axline's practice integrates pharmaceutical-grade peptide therapies with comprehensive metabolic assessments, providing structured programs for patients seeking medically supervised approaches to body composition and metabolic function.

The clinic's peptide therapy menu includes NAD+ (nicotinamide adenine dinucleotide) infusions and supplementation protocols designed to support mitochondrial function and cellular energy production. NAD+ therapy at Texas Med Group targets age-related metabolic decline, cognitive function support, and recovery optimization through intravenous or subcutaneous administration based on patient-specific needs. For weight management, the practice offers both Semaglutide and Tirzepatide—GLP-1 receptor agonist medications that regulate appetite and glucose metabolism. Semaglutide protocols follow weekly injection schedules with dose titration over 16-20 weeks, while Tirzepatide programs utilize the dual GIP/GLP-1 mechanism for patients requiring enhanced metabolic intervention. Dr. Axline's approach includes baseline metabolic panels, body composition analysis, and ongoing monitoring of hemoglobin A1c, lipid profiles, and thyroid function throughout treatment courses.

Dr. Bradley Axline brings board certification in his specialty to the clinical oversight of all peptide and metabolic programs at Texas Med Group. His treatment philosophy emphasizes laboratory-guided dosing adjustments rather than one-size-fits-all protocols, with patients receiving individualized titration schedules based on tolerance, response markers, and metabolic goals. The clinic's medical team conducts initial consultations that include comprehensive health histories, current medication reviews, and contraindication screening before initiating any peptide therapy. This medical supervision model ensures appropriate candidate selection for GLP-1 therapies and NAD+ protocols, particularly for patients with complex medical histories or concurrent prescriptions.

Patients beginning treatment at Texas Med Group in Fort Worth undergo structured onboarding that includes injection technique training for self-administered peptides, side effect management education, and scheduled follow-up intervals. Semaglutide and Tirzepatide patients typically follow monthly check-in protocols during the initial titration phase, with visits including weight tracking, side effect assessment, and dose adjustments as clinically indicated. NAD+ therapy patients may receive in-office infusions or transition to at-home subcutaneous protocols depending on treatment goals and response patterns. The clinic provides direct access to medical staff for questions regarding injection site reactions, gastrointestinal adjustments during GLP-1 therapy, or scheduling modifications based on individual tolerance patterns.

Texas Med Group's Fort Worth location serves patients from surrounding communities including Arlington, Southlake, and Grapevine, with office hours structured to accommodate working professionals. The practice maintains a 4.9-star rating across 48 Google reviews, reflecting patient feedback on medical thoroughness and accessibility of care. While the clinic offers aesthetic services alongside metabolic programs, Dr. Axline's peptide therapy protocols operate as distinct medical weight loss and cellular health interventions with defined eligibility criteria, monitoring requirements, and outcome tracking systems that differentiate them from cosmetic-only practices in the North Texas region.